These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 37535440

  • 21. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M, Sesli Çetin E, Şirin MC, Cicioğlu Arıdoğan B.
    Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
    [Abstract] [Full Text] [Related]

  • 22. Clinical Characteristics and Molecular Insights of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Patients in Intensive Care Units.
    Zhou Y, Mu Y.
    Surg Infect (Larchmt); 2024 Oct; 25(8):606-611. PubMed ID: 38990705
    [Abstract] [Full Text] [Related]

  • 23. High frequency of NDM-1 and OXA-48 carbapenemase genes among Klebsiella pneumoniae isolates in central Iran.
    Abbasi E, Ghaznavi-Rad E.
    BMC Microbiol; 2023 Apr 11; 23(1):98. PubMed ID: 37038144
    [Abstract] [Full Text] [Related]

  • 24. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient.
    Zhou J, Yan G, Tang C, Liu J, Fu P, Ding L, Yang W, Guo Y, Wang C, Lu G, Hu F.
    Int J Antimicrob Agents; 2024 Jun 11; 63(6):107163. PubMed ID: 38570018
    [Abstract] [Full Text] [Related]

  • 25. A challenging case of carbapenem resistant Klebsiella pneumoniae-related pyogenic liver abscess with capsular polysaccharide hyperproduction: a case report.
    Sohrabi M, Pirbonyeh N, Alizade Naini M, Rasekhi A, Ayoub A, Hashemizadeh Z, Shahcheraghi F.
    BMC Infect Dis; 2024 Apr 23; 24(1):433. PubMed ID: 38654215
    [Abstract] [Full Text] [Related]

  • 26. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, Akova M, Yu Y.
    Clin Microbiol Infect; 2020 Jan 23; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [Abstract] [Full Text] [Related]

  • 27. Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa.
    Delgado-Valverde M, Portillo-Calderón I, Alcalde-Rico M, Conejo MC, Hidalgo C, Del Toro Esperón C, Pascual Á.
    Eur J Clin Microbiol Infect Dis; 2024 Mar 23; 43(3):445-457. PubMed ID: 38157139
    [Abstract] [Full Text] [Related]

  • 28. Evolution of blaKPC Under the Pressure of Carbapenems and Ceftazidime/Avibactam in a Patient With Persistent Bacteremia Caused by Klebsiella pneumoniae.
    Won EJ, Park K, Jeong YS, Kim J, Choi Y, Kim SH, Kim MN, Sung H.
    J Korean Med Sci; 2024 Jul 01; 39(25):e208. PubMed ID: 38952349
    [Abstract] [Full Text] [Related]

  • 29. Impact of Ceftazidime-Avibactam Treatment in the Emergence of Novel KPC Variants in the ST307-Klebsiella pneumoniae High-Risk Clone and Consequences for Their Routine Detection.
    Hernández-García M, Castillo-Polo JA, Cordero DG, Pérez-Viso B, García-Castillo M, Saez de la Fuente J, Morosini MI, Cantón R, Ruiz-Garbajosa P.
    J Clin Microbiol; 2022 Mar 16; 60(3):e0224521. PubMed ID: 35107303
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the synergistic effect of eravacycline and tigecycline against carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae.
    Huang YS, Yang JL, Wang JT, Sheng WH, Yang CJ, Chuang YC, Chang SC.
    J Infect Public Health; 2024 May 16; 17(5):929-937. PubMed ID: 38599013
    [Abstract] [Full Text] [Related]

  • 31. New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
    Yu W, Luo Q, Shen P, Chen Y, Xu H, Xiao Y, Qiu Y.
    Int J Antimicrob Agents; 2021 Dec 16; 58(6):106458. PubMed ID: 34706255
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
    Antinori E, Unali I, Bertoncelli A, Mazzariol A.
    Clin Microbiol Infect; 2020 Jul 16; 26(7):946.e1-946.e3. PubMed ID: 32061796
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.